In this thesis, liquid chromatography tandem mass spectrometry based discovery proteomics was explored to portray the dynamic proteomic changes underlying type 1 diabetes (T1D) onset in peripheral CD4+ T cells, CD4-depleted cells and serum. The objective was to identify disease-associated proteomic signatures which lead to a better understanding of T1D pathogenesis, and which ideally exhibit biomarker potential. The generated proteomic landscape of PBMCs and serum provides evidence for distinct alterations in innate and adaptive immune function in recent-onset T1D.
«
In this thesis, liquid chromatography tandem mass spectrometry based discovery proteomics was explored to portray the dynamic proteomic changes underlying type 1 diabetes (T1D) onset in peripheral CD4+ T cells, CD4-depleted cells and serum. The objective was to identify disease-associated proteomic signatures which lead to a better understanding of T1D pathogenesis, and which ideally exhibit biomarker potential. The generated proteomic landscape of PBMCs and serum provides evidence for distinct...
»